Fake data. Lots of it. Falsified. Much of it cancer treatment data! The prolonged scandal involving Dr. Potti, a former Duke University cancer researcher, could have been stopped earlier, according to a report in the Cancer Letter earlier in 2015. As far back as 2008, a Duke medical student, Bradford Perez, was whistle-blower and warned university officials about Dr Potti’s UNwork. But school officials and other researchers silenced the Mr. Perez.

According to an ORI report published online today, November 11, 2015, in the Federal Register, Dr Potti falsified research in all of these studies below, which have now all been retracted:

  • a predictor of thrombotic phenotypes (Blood. 2006107:1391-1396)
  • a predictor of lung cancer relapse (N Engl J Med. 2006; 355:570-580)
  • a predictor of the response to the chemotherapeutic drugs topotecan and docetaxel (Nat Med. 2006;12:1294-1300)
  • a predictor of the response to the chemotherapeutic drug cisplatin (J Clinical Oncol.2007;25:4350-4357)
  • a predictor of the response to the combination of the chemotherapeutic drugs fluorouracil, epirubicin, and cyclophosphamide, or docetaxel, epirubicin, and docetaxel (Lancet Oncol.2007;8:1071-1078)
  • a predictor of breast cancer relapse (JAMA. 2008;299:1574-1587)
  • a predictor for the response to the chemotherapeutic drugs paclitaxel, 5-fluouracil, adriamycin, and cyclophosphamide (PLoS One. 2008;3:e1908)
  • a predictor of colon cancer recurrence (Proc Natl Acad Sci U S A. 2008;105:19432-19437)
  • a predictor of the response to the chemotherapeutic drug cisplatin (Clin Cancer Res. 2009;15:7553-7561)